CSI Market
Sign In | Register

Biolargo Inc (BLGO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BLGO Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Biolargo Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-12.46
Depreciation & amortization0.07
Amortization of Other Assets0.13
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.74
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Fair Value Of Warrant Extension-
Other Significant Noncash Transaction Value Of Consideration Given-
Other Significant Noncash Transaction Consideration Given-
Issuance Of Stock For Payment Of Interest-
Interest Expense Fair Value Of Warrants Issued As Consent For Variable Debt-
Induced Conversion Of Convertible Debt Expense-
Extension Expense Debt-
Increase Decrease In Contract With Customer Liability0.04
Gain From P P P Loan Forgiveness-
Increase Decrease In Right Of Use And Lease Liability Net0.03
Operating Lease Right Of Use Asset Amortization Expense0.05
Capital Expenditures Incurred But Not Yet Paid-
Credit Loss Expense Noncash-
Dividends Payable Current And Noncurrent0.09
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.12
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.00
Accrued Expense0.00
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net-2.35
Payments for (Proceeds from) Other Operating Activities12.77
Discontinued operations-5.97
Net Cash flow from Operating Activities-5.97
Investing Activities
Capital Expenditures-0.19
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Conversion Of Stock Amount Converted-
Debt Conversion Converted Instrument Amount-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Interest in Joint Venture0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.19
Financing Activities
Short-term debt Net-0.13
Other borrowing transactions0.00
Long-term debt - borrowings3.38
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.65
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.57
Proceeds From Sale Of Convertible Notes Payable-
Proceeds From Conversion Inducement-
Proceeds From Adjustment Of Warrant-
Proceeds Payments For From Sale Of Common Stock Net Of Commisions-
Issuance Of Common Stock For Financing Fees0.09
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.47
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-6.17
Total Cash Flow-1.70
4 historic quarters locked

Sign in to unlock the full Biolargo Inc cash flow history.

Sign In Create Free Account

About Biolargo Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-028023

Figures are derived from filed reports and may be restated. Historical data is subject to revision.